600
Participants
Start Date
May 28, 2019
Primary Completion Date
August 31, 2022
Study Completion Date
August 31, 2022
Fingerstick GeneXpert HCV RNA quantitative assay
All participants at risk of HCV infection will receive HCV RNA testing using the GeneXpert finger-stick point-of-care HCV quantitative assay 6 monthly
sofosbuvir/velpatesvir
Participants with active HCV infection will be offered treatment with one of two pan-genotypic regimens available in Australia
glecaprevir/pibrentasvir
Participants with active HCV infection will be offered treatment with one of two pan-genotypic regimens available in Australia
RECRUITING
Walhallow Aboriginal Corporation, Quirindi
RECRUITING
Jullums Lismore Aboriginal Medical Service, Lismore
RECRUITING
Pangula Mannamurna Aboriginal Corporation, Mount Gambier
RECRUITING
Port Lincoln Aboriginal Health Service, Port Lincoln
Lead Sponsor
South Australian Health and Medical Research Institute
OTHER
Flinders University
OTHER
Kirby Institute
OTHER_GOV